10.54
Quidelortho Corp stock is traded at $10.54, with a volume of 1.38M.
It is down -0.52% in the last 24 hours and down -26.96% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
See More
Previous Close:
$10.60
Open:
$10.64
24h Volume:
1.38M
Relative Volume:
0.91
Market Cap:
$722.79M
Revenue:
$2.66B
Net Income/Loss:
$-1.21B
P/E Ratio:
-0.5915
EPS:
-17.82
Net Cash Flow:
$-159.40M
1W Performance:
+1.93%
1M Performance:
-26.96%
6M Performance:
-35.85%
1Y Performance:
-64.21%
Quidelortho Corp Stock (QDEL) Company Profile
Name
Quidelortho Corp
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
QDEL
Quidelortho Corp
|
10.54 | 750.22M | 2.66B | -1.21B | -159.40M | -17.82 |
|
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Downgrade | Citigroup | Buy → Neutral |
| May-08-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corp Stock (QDEL) Latest News
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo! Finance Canada
Quidel Corporation (QDEL) stock price, news, quote and history - Yahoo Finance UK
QuidelOrtho Corporation (QDEL) Stock forecasts - Yahoo Finance UK
QuidelOrtho Corporation (QDEL) Stock Price, News, Quote & History - ca.finance.yahoo.com
Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment - Financial Times
A Look at QuidelOrtho Corp (QDEL) After 5.5% Decline -- GF Value $33.09 vs Price $10.34 - GuruFocus
QuidelOrtho Updates Credit Agreement, Revises Financial Covenants Through 2029 - Kalkine Media
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance
Quidelortho Corp Enters Amendment No. 1 To Credit Agreement On Sept 23, 2026 - TradingView
QuidelOrtho Corporation Enters Into Amendment No. 1 To Existing Credit Agreement - marketscreener.com
Is QuidelOrtho Corp (QDEL) a Bargain After 3.1% Drop? GF Value S - GuruFocus
QDEL stock gains as QuidelOrtho beats estimates and trades near target - ad-hoc-news.de
Respiratory test results can arrive in as little as six minutes - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.4%Should You Sell? - MarketBeat
Tejara Capital Ltd Takes $2.27 Million Position in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Shares Up 6.9%Here's What Happened - MarketBeat
QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally - Stocktwits
QuidelOrtho Corporation’s Margin Recovery Meets China, Respiratory & Cash Flow Headwinds ! - Smartkarma
QuidelOrtho EVP Bryan Hanson Reports RSU Vesting and Tax-Related Share Withholding - Kalkine Media
QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript - AOL.com
QuidelOrtho (QDEL) Earnings Check: Reported EPS Tops Expectations for the Current Session; Market Follow-Through: Shares Close 8.44% LowerLow Estimate Range - Vinanet
Quidelortho Corp (QDEL) News, Articles, Events & Latest Updates - Stocktwits
Rice Hall James & Associates LLC Invests $18.63 Million in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho Corp (QDEL) exec’s RSUs vest as shares withheld for tax - Stock Titan
QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed - Yahoo Finance
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers - StockStory
QuidelOrtho Corp (QDEL) Stock Down 5.2% -- Now Undervalued? GF S - GuruFocus
QuidelOrtho (NASDAQ:QDEL) Stock Rating Lowered by Zacks Research - MarketBeat
QDEL|QuidelOrtho Corp|Price:14.300|Chg%:-0.790 - TradingKey
QuidelOrtho (QDEL) Is Down 7.5% After Cutting 2026 Revenue Outlook Amid Softer COVID Testing Demand - simplywall.st
Invesco Ltd. (QDEL holder) reports 5.1% beneficial stake in QuidelOrtho Corp - Stock Titan
QuidelOrtho (QDEL) Stock Sees Fair Value Cut As Analysts Rework Growth Expectations - Yahoo Finance
QuidelOrtho Corp (QDEL) Stock Up 6.0% and Still Undervalued -- G - GuruFocus
Neuberger Berman Group LLC Trims QuidelOrtho Corp (QDEL) Stake -- Shares Trade 59% Below GF Value - GuruFocus
Why QuidelOrtho (QDEL) Stock Is Nosediving - Yahoo Finance
QuidelOrtho partially recovers from earnings slide, rising 12% (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Shares Up 8.5%Should You Buy? - MarketBeat
QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging - Yahoo Finance
QuidelOrtho Corporation revenue up 3% to USD 631M in Q2 2026 - Medical Buyer
QuidelOrtho Corp (QL1A.DU) options chain - Yahoo Finance Australia
QuidelOrtho (QDEL) Stock Sinks As Cash Burn And Debt Eclipse Progress - simplywall.st
Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July - Benzinga
QuidelOrtho Corporation 2026 Q2ResultsEarnings Call Presentation (NASDAQ:QDEL) 2026-08-07 - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Shares Gap DownTime to Sell? - MarketBeat
QuidelOrtho Corp (QDEL) Stock News Today - TradingKey
QuidelOrtho stock drops after Q2 results (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
QuidelOrtho 2Q Rev $630.9M >QDEL - Moomoo
AUG 06 (REUTERS)QUIDELORTHO Q2 REVENUE USD 630.9 MILLION. - Moomoo
QuidelOrtho Q2 Earnings Call Highlights - MarketBeat
QuidelOrtho Corp Q2 2026: Revenue $630.9M, EPS $(1.36) — 10-Q Summary - TradingView
Quidelortho Corp Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quidelortho Corp Stock (QDEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hanson Bryan Michael | EVP Global Port. Mgmt & Mkting |
Aug 15 '26 |
Option Exercise |
0.00 |
446 |
0 |
8,217 |
| Hanson Bryan Michael | EVP Global Port. Mgmt & Mkting |
Jul 01 '26 |
Option Exercise |
0.00 |
5,797 |
0 |
9,867 |
| Strobeck Matthew | Director |
Feb 13 '26 |
Buy |
23.96 |
10,000 |
239,586 |
27,775 |
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):